Professional Documents
Culture Documents
DRUG
IN
New to this edition
• New Chapter 5, Images of Drugs in Popular Culture
• New Chapter 9, Drug Pharmacology and Pharmacotherapy Treatments
• New chapter on primary prevention (Chapter 7)
• New case study feature to help readers see the application of theory to
practice
• Expanded range of discussion questions, useful for classroom discussion
AUSTRALIAN SOCIETY
and helping readers develop their understanding of key issues
• Completely updated with current policy and references
Alison Ritter is the Director of the Drug Policy Modelling Program (DPMP) and
Deputy Director of the National Drug and Alcohol Research Centre (NDARC) at the
University of New South Wales.
Trevor King is the Director of Programs at UnitingCare ReGen Alcohol and Drug
Service.
Nicole Lee is an Adjunct Associate Professor at the National Drug Research
Institute, Curtin University and director at 360Edge, a specialist consultancy for
service and workforce development in the alcohol and other drug sector.
Second Edition
Second
Edition
Edited by
Ritter
King
Lee
ISBN 978-0-19-030645-8
Edited by
Alison Ritter
9 780190 306458 Trevor King
visit us at: oup.com.au or
contact customer service: cs.au@oup.com Nicole Lee
Chapter 12: Drug Law Enforcement: Reducing the Supply of Drugs 247
Lorraine Mazerolle and Jenna Thompson
Chapter 13: Making Drugs Policy: Policy Models and Influences on Policy
Processes 266
Alison Ritter and Kari Lancaster
Glossary 292
Bibliography 313
Index 364
Expanded Contents
Abbreviations xiii
Chapter 1: Introduction 1
Alison Ritter, Trevor King and Nicole Lee
Introduction 2
Why do people use psychoactive drugs? 5
What are the harms associated with psychoactive drugs? 6
Terminology: labels matter 11
Responses to drugs 12
The ‘three pillars’ 13
Reconciling licit and illicit drug policies? 14
Book overview 16
Risk and protective factors for alcohol and other drug use 130
When should prevention occur? 132
Where should prevention occur? 132
School-based prevention approaches 134
Non-school-based prevention 138
Future directions 140
Chapter 8: Harm Reduction: Reducing the Harms from Drug Use 144
Craig Rodgers and Ingrid van Beek
Introduction 145
Illicit drugs 148
Alcohol 159
Tobacco 162
Indicators of injecting drug use harm reduction uptake 166
Australian harm reduction –successes and failures 166
Harm reduction: the politics of drug policy and the ongoing criminalisation of drug use 168
Chapter 12: Drug Law Enforcement: Reducing the Supply of Drugs 247
Lorraine Mazerolle and Jenna Thompson
Introduction 248
Overview of different levels of drug law enforcement interventions 249
Current challenges for drug law enforcement 251
Transborder drug law enforcement 252
Mid-level or intra-border drug law enforcement 255
What is (and is not) effective drug law enforcement 257
Future challenges 262
Glossary 292
Bibliography 313
Index 364
Figures
1.1 The relationship between harm and availability 15
3.1 Smoking prevalence rates for males and females, Australia 1945–2013 47
3.2 Per capita consumption of alcohol (litres absolute alcohol), Australia 1800–2012 48
3.3 Percentage of per c
apita consumption of alcohol (litres absolute alcohol)
by beverage type, Australia, 1960/61–2013/14 49
3.4 Opioid prescriptions of selected opioids in Australia, 1992–2012 55
3.5 Rate of deaths due to opioids per million persons aged 15–54, 1988–2011 58
3.6 Percentage of total closed treatment episodes for the four most frequently
presenting primary drug problems recorded in the Alcohol and Other
Drug Treatment Services National Minimum Data Set 61
3.7 Drug-related arrests (consumer and provider) in Australia, 2004/05–2013/14 62
4.1 Governing ideas about alcohol, tobacco and other drugs 75
4.2 Schema of frames of social handling of substance use problems 76
7.1 The mental health intervention spectrum 126
9.1 Comparison of full agonist, partial agonist and antagonist effects 187
12.1 Drug activity pyramid 250
12.2 Dimensions of policing strategies 256
Tables
1.1 Policy options and the three pillars of drug policy 13
3.1 Prevalence of alcohol consumption in Australia by risk level, age and gender, 2013 50
3.2 Prevalence of reported recent (past year) use of drugs, National Drug Strategy
Household Surveys 2001–13 52
3.3 Prevalence of selected drug use conditions in Australia, 2007 56
3.4 Hospitalisations by drug-related principal diagnosis and duration, 2013–14
(number and percentage) 59
7.1 Risk and protective factors 131
7.2 Types of prevention settings 133
7.3 Characteristics of comprehensive social-influence prevention programs 137
9.1 Some common signs and symptoms of acute opioid effects and opioid
withdrawal 178
9.2 Overview of pharmacological treatment options for opioid dependence 188
9.3 Overview of pharmacological treatment options for nicotine dependence 194
11.1 Australian data on consumer and provider arrests, state/territory and gender,
year to 30 June 2014 233
11.2 Detected illicit drug offenders, Australia, 2014–15, by age group 234
13.1 Comparisons of international approaches to drug policy 270
13.2 Policy levers and examples 281
Boxes
Box 1.1 What do we mean by ‘drugs’? 3
Box 1.2 Reasons that people consume drugs 5
Theory to practice Fears of a cocaine epidemic 35
Theory to practice Different windows on alcohol-related child abuse and neglect 64
Box 4.1 Main governing images and frames of understanding problems
with drugs72
Box 5.1 Analysis of Australian news media and drugs 86
Theory to practice Australian media reports on methamphetamine research 90
Theory to practice Adulterants: the case of NBOMe drugs as adulterants to LSD or
MDMA113
Case study School-based drug education 137
Theory to practice Sydney’s Medically Supervised Injecting Centre 151
Box 9.1 Psychoactive drug classification 176
Box 9.2 Common synthetic cannabinoids 182
Box 9.3 Example DSM-5 opioid use disorder criteria 185
Case study Treating heroin dependence 190
Box 10.1 Example DSM-5 criteria for stimulant use disorder 202
Case study Case formulation: psychological treatment 204
Box 10.2 Examples of freely available alcohol and drug self-help and
treatment websites 210
Box 10.3 The twelve steps of Alcoholics Anonymous 217
Box 11.1 Drug law options 227
Theory to practice A music festival, ‘sniffer’ dogs and Ella 229
Box 11.2 Laws on new psychoactive substances 230
Box 11.3 Australian data on arrests 234
Box 11.4 The offence of self-administration of illegal drugs 240
Theory to practice Using computer simulation models to test drug law enforcement 261
Box 13.1 Prohibition, depenalisation, decriminalisation, legalisation 274
Box 13.2 Types of evidence for use in drug policy 278
Theory to practice The application of different policy process theories to the
medically supervised injecting centre, Sydney 284
Abbreviations
BI Brief Intervention
CN Contingency Management
MI Motivational Interviewing
NBOMe N-methoxybenzyl
NMDA N-methyl-d-aspartate
RP Relapse Prevention
TC Therapeutic Community
THC Δ-9-tetrahydrocannabinol
TSF Twelve-
Step Facilitation
UN United Nations
UNSCAP United Nations Economic and Social Commission for Asia and the Pacific
Professor Alison Ritter is a leading drug policy researcher and Director of the Drug Policy
Modelling Program (DPMP) at the National Drug and Alcohol Research Centre (NDARC) at the
University of New South Wales. She is a National Health and Medical Research Council Senior
Research Fellow (from 2012 to 2017) leading a collaborative, multi-disciplinary program of
research on drug policy. Professor Ritter worked as a clinical psychologist in the alcohol and
drug treatment sector prior to commencing full-time research. She was the Deputy Director of
Turning Point Alcohol and Drug Centre from 1995 to 2005. She is the Immediate Past President
of the International Society for the Study of Drug Policy, Vice-President of the Alcohol and Drug
Council of Australia and an editor for a number of journals. Professor Ritter has an extensive
research grant track record. She has published widely in the field including two edited books,
multiple book chapters and more than 150 other publications.
Trevor King is Director of Programs at Uniting: ReGen Alcohol and Drug Service in Melbourne.
He has worked in the drug and alcohol sector for over 35 years. Over this time he has held
senior positions in the government and non- government sectors including manager of
methadone and needle and syringe programs for the Victorian Department of Human Services
in the late 1980s; Director of Community Programs –Drug Services Victoria in the early 1990s;
Head of Education and Training Services at Turning Point Alcohol and Drug Centre from 1995
to 2005 and Deputy Director from 2006 to 2009; and Deputy Director of the Drug Policy
Modelling Program from 2009 to 2013. At this time he also had a research translation role at
the Burnet Institute –Centre for Research Excellence into Injecting Drug Use. His roles have
included co-author of the most recent national alcohol strategy; membership of the Capital City
Lord Mayor’s Drug Advisory Committee; and Australian representative on the United Nations
Office of Drugs and Crime: Global Network of Drug Treatment Centre’s (TreatNet).
Professor Nicole Lee is Adjunct Professor at the National Drug Research Institute, Curtin
University and Director at 360Edge, a specialist consultancy for service and workforce
development in the alcohol and other drug sector. She is a consultant psychologist with
25 years’ experience in research and evaluation, training and workforce development, clinical
practice and service management. Nicole was previously Head of Research at Turning Point
Alcohol and Drug Centre. She is the Immediate Past National President of the Australian
Association for Cognitive and Behaviour Therapy and Deputy Editor at the Drug and Alcohol
Review Journal. She has previously served on the boards of the Alcohol and Other Drugs
Council of Australia (ADCA) and Australasian Professional Society on Alcohol and other Drugs
(APSAD). She has consulted to the World Health Organization and the United Nations Office on
Drugs and Crime as well as international, Australian and state governments. Nicole has written
more than 100 journal articles, books, book chapters and clinical practice guides.
Professor Amanda Baker is a National Health and Medical Research Council Senior Research
Fellow in the School of Medicine and Public Health at the University of Newcastle, New South
Wales. She is the President of the Australian Association of Cognitive Behaviour Therapy (from
2016 to 2019) and also Co-Director of a Centre of Research Excellence in Mental Health and
Substance Use (from 2013 to 2017). Amanda has a major interest in multiple health behaviour
change, addressing mental health, smoking, substance use and diet and activity levels among
people with mental health and/or substance use disorders. She leads a program of clinical
research, trialling novel interventions that target coexisting mental health and substance use
problems. Amanda is also a senior clinical psychologist and has practised in mental health,
forensic and alcohol and other drug treatment settings in the United Kingdom and Australia.
Dr Monica J. Barratt is a National Health and Medical Research Council Postdoctoral Fellow
at the Drug Policy Modelling Program at the National Drug and Alcohol Research Centre at the
University of New South Wales. She trained in psychology, sociology and public health, and has
over 10 years’ experience conducting mixed-methods research into drug use practices and
policies in increasingly digitised societies. Monica leads a program of work investigating the
newest trends in drug markets: new or novel psychoactive substances, high-dose MDMA pills
and powders, and internet-facilitated drug supply, including darknet markets or cryptomarkets,
webstores and app-based drug trading. She previously worked in research at Turning Point
Alcohol and Drug Centre and the National Drug Research Institute, Curtin University, where she
currently holds an adjunct research position. She is also a Visiting Fellow at the Burnet Institute,
lead Australian researcher on the Global Drug Survey, Associate Editor at the International Journal
of Drug Policy, Assistant Editor at the Drug and Alcohol Review, and the Director of Research
at the international drug harm reduction community, Bluelight.org. Monica publishes regularly in
drugs and methods journals (over 60 peer-reviewed articles, letters and chapters) as well as to
the wider public (over 100 media appearances and five articles in The Conversation, an online
news source written by academics in collaboration with journalists).
Louise Birrell is a Research Officer at the National Drug and Alcohol Research Centre. She
works as part of the prevention team at the Centre of Research Excellence in Mental Health and
Substance Use, which seeks to improve treatment, prevention and epidemiology for comorbid
drug, alcohol and mental health conditions. Louise has worked on the first online preventative
trial to combine substance use education with depression and anxiety education for high
school students, as well as numerous other school-based prevention research trials. She has
also worked as a Lifeline crisis telephone counsellor at Lifeline Harbor to Hawkesbury and has
counselled many individuals facing mental health and other crises.
Dr Adrian Carter is Senior Research Fellow and Head, Neuroethics and Public Policy Group at the
School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences,
Monash University, and Director, Neuroethics Program, Australian Research Council Centre of
Excellence for Integrative Brain Function. His research examines the impact that neuroscience
has on our understanding and treatment of addiction and other compulsive behaviours. Adrian
is currently funded by a National Health and Medical Research Council Career Development
Fellowship (2017–21). He received the Australasian Professional Society of Alcohol and Other
Drugs ‘Early Career Award for Excellence in Research and Science’ (2012) and the Australian
National Drug and Alcohol Award for Excellence in Research (2010). He has over 120 publications,
including the book Addiction Neuroethics: The Promises and Perils of Addiction Neuroscience’
(Cambridge University Press, 2012). Adrian has been an adviser to the World Health Organization,
the European Monitoring Centre for Drugs and Drug Addiction, the Australian Ministerial Council
on Drugs Strategy and United Nations Office on Drugs and Crime. He is also Deputy Chair of the
Australian Academy of Science Early and Mid Career Research Forum Executive.
Dr Katrina Champion is a National Health and Medical Research Council Early Career Research
Fellow at the Centre of Research Excellence in Mental Health and Substance use at the
National Drug and Alcohol Research Centre. Katrina’s research focuses on the development,
evaluation and dissemination of online resources to improve the health and wellbeing of
Australians. Her PhD (University of New South Wales, 2016) resulted in the development and
evaluation of the first online prevention program for ecstasy and new psychoactive substances.
Katrina has also worked on a large trial of a combined universal and selective substance
use prevention program (CAP Study) since 2011, and is Project Manager of an Australian
Government Department of Health study to develop an online community toolkit about crystal
methamphetamine. Dr Champion has published in leading addiction and prevention journals,
and is an Early Career Reviewer for Prevention Science.
Professor Paul Dietze is an epidemiologist working in the field of alcohol and other drugs. He has
established new surveillance systems as well as conducted specific research projects that break
new ground in the epidemiology of heroin overdose in particular. Paul has been involved in the
development and implementation of a variety of heroin overdose prevention initiatives, including
take-home naloxone programs in Australia and was a member of the World Health Organization
(WHO) Guidelines Development Group for the Guidelines on the Management of Opioid Overdose.
He is currently Executive Editor of Drug and Alcohol Review, one of the leading scientific journals
in the alcohol and other drugs field. Paul is a past Australian Research Council Future Fellow and
a current National Health and Medical Research Council Senior Research Fellow.
Dr Natasa Gisev is a pharmacist and a National Health and Medical Research Council Early
Career Research Fellow based at the National Drug and Alcohol Research Centre, University of
New South Wales. Over the last 10 years she has worked across a number of different settings
including community pharmacy, hospital pharmacy and academia (both teaching and research).
Her main area of research expertise and interest is in pharmacoepidemiology and the use of
linked administrative data sets to examine the patterns and outcomes associated with medicines
use in complex populations, including older adults, people with mental health disorders and
people with substance use disorders. Natasa recently completed work on a large data linkage
study which examined the impact of opioid substitution therapy on crime and mortality, with a
particular focus on the outcomes of prisoners. She is currently working on a number of projects
examining the pharmacoepidemiology of opioid medicines to identify the potential burden, risks
and harms associated with the use of these medicines in the Australian population.
Professor Wayne Hall is the Director of the Centre for Youth Substance Abuse Research at
the University of Queensland and a Professor at the National Addiction Centre, King's College
London. He also has visiting professorial appointments at the London School of Hygiene and
Tropical Medicine and the National Drug and Alcohol Research Centre, University of New South
Wales. Wayne was formerly a National Health and Medical Research Council Australia Fellow at
the University of Queensland Centre for Clinical Research and the University of Queensland Brain
Institute (from 2009 to 2014); Professor of Public Health Policy, School of Population Health,
University of Queensland (from 2005 to 2009); Director of the Office of Public Policy and Ethics at
the Institute for Molecular Bioscience (from 2001 to 2005), University of Queensland; and Director
of the National Drug and Alcohol Research Centre, University of New South Wales (from 1994 to
2001). He has advised the World Health Organization on the health effects of cannabis use; the
effectiveness of drug substitution treatment; the contribution of illicit drug use to the global burden
of disease; and the ethical implications of genetic and neuroscience research on addiction.
Dr Caitlin Hughes is a criminologist and Senior Research Fellow at the National Drug and
Alcohol Research Centre, University of New South Wales, Australia, where she works as part of
the Drug Policy Modelling Program. Her research focuses on evaluating and informing drug laws;
evaluating and informing criminal justice policies (including alternatives to arrest); monitoring
trends in drug trafficking and drug markets; and researching the policy processes by which drug
policy is informed and made. Caitlin has written over 40 peer-reviewed articles, book chapters
and reports. She has spent many years analysing the impacts of the Portuguese decriminalisation
of illicit drugs, as well as Australian drug laws and the complexities of Australia’s system of de
facto decriminalisation of illicit drug use and possession. Her research has also contributed to
direct policy change in Australia, including the redesign of drug trafficking thresholds limits and
the expansion of drug diversion programs.
Dr Kari Lancaster is a Research Associate at the Drug Policy Modelling Program, National
Drug and Alcohol Research Centre, University of New South Wales, Australia. Since joining the
Drug Policy Modelling Program in 2009, Kari has undertaken qualitative research investigating
policy processes, with a particular interest in examining ‘problematisation’ and how drug
policy problems and policy knowledge(s) are constituted. A selection of projects, past and
present, include investigating strategic advocacy processes in the establishment of overdose
prevention and management programs, analysis of the emergence of methamphetamine as
a policy issue in Australia, and examining the science–policy interface in drug policy. Kari has
collaborated with the Australian Injecting & Illicit Drug Users League to investigate how people
who use drugs perceive drug policy, and also the Australian National Council on Drugs to
explore young people’s ideas about responding to alcohol and other drug issues.
Dr Anne-Marie Laslett is a senior research fellow at the National Drug Research Institute, Curtin
University and a research fellow at the Centre for Alcohol Policy Research, La Trobe University.
She has worked in the area of alcohol and drug social epidemiology at Centre for Alcohol Policy
Research and Turning Point for the past 20 years and currently directs the Range and Magnitude
of Alcohol’s Harm to Others project. While this research has involved a wide range of health and
social health problems, the current emphasis of Anne-Marie’s research is on alcohol’s harm to
children for which she has a National Health and Medical Research Council fellowship. She is also
a co-investigator and technical adviser to the World Health Organization–Thai Health international
collaborative research project on the harm to others from drinking, and is the coordinator of the
International Group for the Study of Alcohol’s Harm to Others.
Professor Simon Lenton is the Director at the National Drug Research Institute at Curtin University,
where he has worked since 1993. In addition, he works part time as a clinical psychologist in
private practice. His research interests include bridging the gap between drug policy research
and drug policy practice, illicit drug use and harm reduction, the impact of legislative options
for drugs, and the wider availability of naloxone to prevent opioid overdose deaths. Simon has
published widely on drugs, health and the law and provided advice to a range of government
and private organisations, both in Australia and internationally, on evidence-based drug policy
and other drug issues.
Dr Sarah MacLean is Senior Lecturer in the Department of Community and Clinical Allied Health
at La Trobe University and is an affiliate of the Centre for Alcohol Policy Research. Much of Sarah’s
research has explored people’s experiences of alcohol and other drug use. Her PhD was a study
of the social meanings of inhalant use for marginalised young people. Sarah was awarded an
Australian Research Council postdoctoral fellowship to investigate cultures that frame alcohol
use among young adults in inner and outer urban areas of Melbourne (from 2010 to 2014). Her
current research entails trialling a family empowerment intervention to address substance use
within an Aboriginal community.
David McDonald is the Director of Social Research & Evaluation Pty Ltd. David is a social
scientist with research interests in public health and criminology, particularly alcohol and other
drugs policy and better understanding the research–policy nexus. As well as being a Consultant
in Social Research and Evaluation, he is a Visiting Fellow at the Australian National University’s
National Centre for Epidemiology and Population Health, and a collaborator with the Drug
Policy Modelling Program research team. David’s academic qualifications are BA, DipSocWork
(Sydney), MA (Alberta), Grad Dip Population Health (Australian National University). He has wide
experience in research, policy and program development and evaluations in the alcohol and
other drugs, criminal justice and related fields. In 2011, he was inducted into the National Drug
and Alcohol Honour Roll.
Associate Professor Nicola Newton is a senior researcher at the National Drug and Alcohol
Research Centre, University of New South Wales and Director of Prevention Research at the
National Health and Medical Research Council Centre of Research Excellence in Mental Health
and Substance Use. Prior to this, she held a competitive University of New South Wales Vice-
Chancellor’s Research Fellowship, providing her the opportunity to spend two years at the Institute
of Psychiatry, King’s College London (from 2010 to 2011). She leads a large program of research
developing, evaluating and translating online and innovative approaches to prevent substance
use and mental health problems. Nicola has received national and international recognition for
her research, most recently the 2014 Australian Institute of Policy and Science Young Tall Poppy
Award for outstanding scientific research. She has published in leading international journals
including Journal of Child Psychology and Psychiatry, Preventive Medicine and Addiction and a
recent article the prestigious journal JAMA Psychiatry.
Dr Suzanne Nielsen is a Senior Research Fellow at the National Drug and Alcohol Research
Centre. In addition she works as a part-time pharmacist in a specialist drug and alcohol service,
with over 15 years’ clinical experience in community pharmacy and specialist drug treatment
settings. Her research work has examined different aspects of opioid substitution treatment and
stimulant treatment, and her current research has focused on understanding and responding to
dependence to pharmaceutical drugs, including prescribed and over-the-counter opioids, and
benzodiazepines. Suzanne also conducts research examining opioid use in chronic pain treatment,
and in understanding best practice for the treatment of concurrent pain and opioid dependence.
Dr Amy Pennay is a National Health and Medical Research Council Early Career Fellow in the
Centre for Alcohol Policy Research at La Trobe University. Amy completed an ethnographic PhD
in 2012, which explored the social, cultural, economic and environmental influences of alcohol
and party drug use among a group of young adults. She has worked in alcohol and drug research
for more than 10 years, using a diverse range of methodologies, but has a particular interest
in qualitative research. Amy’s research has primarily focused on risky drinking, drug use and
energy-drink use in the night-time economy, but she also has an interest in cultures of drinking
and stigma, relating to socio-economic status, ethnicity and sexual orientation.
Dr Craig Rodgers has been working as Staff Specialist in Addiction Medicine at St Vincent’s
Hospital, Darlinghurst, since 2012. He initially completed General Practice training in 2000 and
was then accepted as a Foundation Fellow in the Royal Australasian College of Physicians,
Chapter of Addiction Medicine in 2005. Prior to commencing work at St Vincent’s Hospital,
he enjoyed 10 years as the Medical Unit Manager of the Kirketon Road Centre in Kings Cross,
which provides HIV prevention, treatment and care to ‘at risk’ young people, sex workers and
people who inject drugs as well as a methadone access program for more highly marginalised
drug users. He has also completed a master’s degree in Public Health at the University of New
South Wales in 2005 and is a Conjoint Lecturer with the University of New South Wales via the
St Vincent’s Clinical School. In addition to his work in addiction medicine he continues to work in
general practice and is also a Clinical Advisor for the Australasian Society of HIV Medicine, where
he contributes regularly to their training programs as well as to the further education of general
practice and addiction medicine registrars.
Professor Robin Room was a researcher at the National Alcohol Research Centre (Berkeley,
California) from 1963 to 1991, and the Scientific Director from 1977 to 1991. He was Vice-
President for Research at the Addiction Research Foundation of Ontario, Canada, from 1991 to
1998. In 1999 Professor Room was appointed Professor and Founding Director of the Centre
for Social Research on Alcohol and Drugs at Stockholm University, and retains an adjunct
appointment there. In March 2006, he returned to Australia as a professor at the University
of Melbourne, heading the Centre for Alcohol Policy Research, then at Turning Point Alcohol
and Drug Centre. In 2015, along with the centre, he moved to his current positions at La Trobe
University. He is a long-time adviser for the World Health Organization, and is Editor-in-Chief of
Drug and Alcohol Review. Robin’s research is on social, cultural and epidemiological studies of
alcohol, drugs and gambling behaviour and problems, and studies of social responses to alcohol
and drug problems and of the effects of policy changes. He has received awards for scientific
contributions in the United States, Sweden and Australia, and the premier international award in
alcohol studies, the Jellinek Memorial Award for Alcohol Studies.
Associate Professor Mark Stoové is head of Public Health at the Burnet Institute in Melbourne,
Australia, and has researched the transmission and impact of sexually transmitted infections
and blood-borne viruses among key risk populations, primarily people who inject drugs and
men who have sex with men, for over 15 years. His research interests focus on undertaking
innovative epidemiological and public health research and disease surveillance, with particular
interests in prospective observational studies and the application of record linkage and bio-
behavioural data collection to these study designs. He currently leads a large National Health
and Medical Research Council-funded prospective cohort study following people with a history
of injecting drug use following their release from prison, and is a chief investigator on Australia's
largest prospective study of community recruited people who inject drugs. Mark has published
over 100 peer-reviewed journal articles and assumes editorial and review responsibilities across
several international journals.
Professor Maree Teesson is the Director of the National Health and Medical Research Council
Centre of Research Excellence in Mental Health and Substance Use, a National Health and
Medical Research Council Principal Research Fellow at the National Drug and Alcohol Research
Centre, Australian Academy of Health and Medical Sciences Fellow, a Fellow of the Academy of
Social Sciences in Australia, and Professorial Fellow at the Black Dog Institute, University of New
South Wales. Maree was awarded the Australian Museum Eureka Prize for Outstanding Mentor of
Young Researchers. In 2014, she was named one of the Australian Financial Review/Westpac’s
100 Women of Influence in the category of innovation. She has made a major contribution to
Australia’s health and medical research effort in the field of mental health and substance use. In
particular, she is known nationally and internationally for her research on the comorbidity between
mental health and substance use disorders.
Dr Jenna Thompson is a Technical Analyst within the Department of Defence located in Canberra,
Australia. She completed her Bachelor of Science in the field of mathematics at the University
of Queensland in 2010. In June 2011, Jenna graduated with first-class honours in mathematics
from the University of Queensland with her thesis on Authentication Schemes (Cryptography).
In 2016, she completed her PhD thesis on graph algorithms and motif identification in complex
networks.
Dr Ingrid van Beek, AM MBBS MBA FAFPHM FAChAM MD, is a public health and addiction
medicine physician who has worked at the sharp end of harm reduction for the past 30 years.
Ingrid has been the Director of the Kirketon Road Centre (KRC) since 1989. Located in Sydney's
Kings Cross, KRC is among the world's most comprehensive primary health care services
targeting the needs 'at risk' young people, people who inject drugs and sex workers. Ingrid was
also the founding Medical Director of the Sydney Medically Supervised Injecting Centre from
2000 until 2008, which was the first and still only service of this kind in Australia. Ingrid became a
member of the Order of Australia (AM) in recognition of her contribution to public health in 2010.
She also became a doctor in medicine (MD) that same year in recognition of her significant body
of published work in the international field of Harm Reduction.
1
Introduction
Alison Ritter, Trevor King and Nicole Lee
Overview
1 This chapter provides an introduction to drug use in Australian society.
2 Drugs are psychoactive substances and include alcohol, tobacco, heroin, cocaine, cannabis,
methamphetamine, LSD and ecstasy (MDMA) to name a few.
3 We are reminded that drug use has occurred over millennia and there are many reasons that people
consume drugs. These include for pleasure, to manage aspects of living, to manage emotions, to
reduce pain, to increase a sense of belonging, to expand consciousness, and/or to counteract the
effects of another drug.
4 While most drug use is not harmful, there are harms associated with more intensive drug use.
These include health, social and economic consequences. Harm can also vary for different parts of
Australian society, and we summarise issues for specific sub-populations, such as young people,
Indigenous populations, women, elderly people, those from culturally and linguistically diverse
backgrounds, and others.
5 Terminology matters, and many terms used to describe drug use and the people who use drugs
can be stigmatising. Terms such as ‘addict’, ‘alcoholic’ and ‘injecting drug user’ are not benign and
can result in discrimination, stigma and prejudice.
The periproct (Fig. 228, 4) is covered with small plates and bears a
few pedicellariae. The peristome (Fig. 229) is covered by flexible
skin with abundant pedicellariae; it terminates in a thick lip
surrounding the mouth, from which the tips of five white teeth are just
seen projecting. There are ten short tube-feet projecting from the
peristome—one pair in each radius—and each tube-foot terminates
in an oval disc and is capable of little extension, and each has
around its base a little plate. The presence of these tube-feet shows
that in Echinus the peristome extends outwards beyond the water-
vascular ring, whereas in Asteroidea it is contained entirely within the
ring. In the primitive Cidaridae (Fig. 235) the whole peristome down
to the lip surrounding the mouth is covered with a series of
ambulacral and interambulacral plates similar to those forming the
corona, though smaller and not immovably united, and the series of
tube-feet is continued on to it. It is thus evident that the peristome is
merely part of the corona, which has become movable so as to
permit of the extension of the teeth. In Echinus the peristome is
continued in each interradius into two branched outgrowths called
gills, the relation of which to the respiratory function will be described
later. These gills (Fig. 229, 2) are situated in indentations of the edge
of the corona called "gill-clefts" (Fig. 230, g).
The term ambulacral plate, applied to the plate pierced by the pores
for the tube-feet, conveys a misleading comparison with the
ambulacral plate of an Asteroid. In Echinoids the ambulacral groove
has become converted into a canal called the "epineural canal," and
the ambulacral plates form the floor, not the roof, of this canal; they
may perhaps correspond with the adambulacral plates of the
Starfish, which one may imagine to have become continually
approximated as the groove became narrower until they met.
Fig. 231.—Dissection of Echinus esculentus. × 1. The animal has been opened
by a circumferential cut separating a small piece of the skeleton at the
aboral end, which is turned outwards exposing the viscera on its inner
surface. The other viscera are seen through the hole thus made. amp,
Ampullae of the tube-feet; aur, auricle; b.v, so-called "dorsal blood-vessel";
comp, "compasses" of Aristotle's lantern, often termed "radii" by English
authors; comp.elv, elevator muscles of the compasses; comp.ret, retractor
muscles of the compasses; eph, epiphyses of the jaws in Aristotle's lantern;
gon, gonad; g.rach, genital rachis; int, intestine; oe, oesophagus; prot,
protractor of Aristotle's lantern; rect, rectum; ret, retractor of Aristotle's
lantern; siph, siphon; st, stomach; stone.c, stone-canal.
The buccal tube-feet (Fig. 229, 4) are much shorter than the rest,
and are provided with oval discs which are highly sensory. These
feet are not used for seizing, but for tasting food; when a piece of
food is placed near them they are thrown into the most violent
agitation.
Fig. 232.—Diagrammatic transverse section of the radius of an Echinoid.
amb.oss, Ambulacral ossicle; amp, ampulla of the tube-foot; ep, epineural
canal; musc, muscles attaching spine to its boss; nerv, nervous ring in base
of spine; n.r, radial nerve-cord; oss, ossicle in sucker of tube-foot; ped,
tridactyle pedicellaria; perih, radial perihaemal canal; pod, tube-foot; wv.r,
radial water-vascular canal.
The nervous system has the same form as in an Asteroid, viz. that
of a ring surrounding the mouth and giving off radial nerve-cords
(Fig. 232, n.r), one of which accompanies each water-vascular canal
to the terminal tentacle, where it forms a nervous cushion in which
pigmented cells are embedded.
When a piece of glass rod or other light object is laid on the spines of
a Sea-urchin, it naturally, by its weight, presses asunder the spines
and stretches their muscles on one side, thus lowering the tone. If
now the skin be stimulated at any point the piece of rod will be rolled
by the spines towards the point of stimulation. This is caused by the
fact that the muscles of the spines holding the rod are made more
receptive by being stretched, and therefore they contract more than
do the others in response to the stimulation, and so the rod is rolled
onwards on to the next spines, which then act in the same manner.
This passage of stimulus is entirely independent of direct nervous
connexion between the bases of the spines, for it will traverse at
right angles a crack going clean through the shell; it is merely the
result of the mechanical weight of the object and of the juxtaposition
of the spines.
If the stimulation be too violent the first spines affected diverge wildly
and strike their neighbours with vehemence, so arousing into activity
the block musculature of these. This causes them to stand rigidly up,
and so the path of the stimulus is barred.
Now the escape movements of the animal under strong stimulation
which Romanes[480] alludes to are just an example of this handing
on of stimulation from spine to spine, not by nervous connexion but
by mechanical touch only; the object in this case is the substratum
on which the animal lies, which is, so to speak, rolled towards the
point of stimulation, or putting it otherwise, the animal is rolled away
from it. Righting when upset is another example of the same
phenomenon; the aboral spines are stretched by the weight of the
animal, and the animal acts as if it were stimulated in the region of
the periproct. When a Sea-urchin is in its normal position and is
stimulated in the periproct (as for instance by a strong light), it would,
according to this rule, tend to move downwards, which is of course
impossible; but as the stimulus never affects all sides quite alike the
result is that the Urchin rotates, turning itself ever away from the
point of strongest stimulation. In the case of Strongylocentrotus
lividus when living on limestone, as on the west coast of Ireland, this
results in the animal excavating for itself holes in the rock, where it is
safe from the action of the breakers.[481]
The central nervous system is, however, the system which controls
the movements of the tube-feet. As we have seen, extensions of the
radial nerves run to the tip of each podium. Tube-feet are chiefly
used in ordinary progression; when this is quickened the spines
come into play exclusively. The extent to which these two organs of
locomotion are used varies from genus to genus. Thus
Centrostephanus uses its spines a good deal, Echinus and
Strongylocentrotus very little. The last-named genus sometimes
walks on its tube-feet entirely without touching the ground with its
spines.
Besides the tips of the tube-feet the Urchin possesses another kind
of sense-organ, the sphaeridia (Fig. 233). These are minute glassy
spheres of calcareous matter attached by connective tissue to
equally minute bosses on the plates of the ambulacra, generally near
the middle line. They are in fact diminutive spines, and like the latter
are covered with a thick layer of ectoderm, beneath which is a
particularly well-developed cushion of nerve-fibrils. Only the layer of
muscles which connects a normal spine with its boss is wanting.
Although definite experimental proof is lacking, the whole structure of
the sphaeridia shows that they belong to the category of "balancing
organs." As the animal sways from side to side climbing over uneven
ground, the heavier head of the sphaeridia will incline more to one
side or to another, and thus exercise a strain on different parts of the
sheath, and in this way the animal learns its position with regard to
the vertical.
In the outer wall of this space are developed the calcareous rods
forming Aristotle's lantern. These are first: five teeth (Fig. 234, 11),
chisel-shaped ossicles of peculiarly hard and close-set calcareous
matter, the upper ends (1) pushing out projections of the upper wall
of the lantern-coelom. These projections are the growing points of
the teeth, whose lower ends pierce the ectoderm and project into the
lower end of the oesophagus. Each tooth is firmly fixed by a pair of
ossicles inclined towards one another like the limbs of a V and
meeting below. Each ossicle is called an "alveolus," and taken
together they form a "jaw." Their upper ends are connected by a pair
of ossicles called "epiphyses" (13). These two epiphyses meet in an
arch above. The jaws and their contained teeth are situated
interradially. Intervening between successive alveoli are radial pieces
called "rotulae," which extend directly inwards towards the
oesophagus. Above the rotulae are pieces termed "radii" or
"compasses" (2), which are not firmly attached to the other pieces
but lie loosely in the flexible roof of the lantern-coelom.
The genital rachis springs from the upper end of the stolon, and as in
Asteroids, it lies in the outer wall of a space called the "aboral sinus"
(Fig. 234, 20) intervening between it and the test. In adult specimens
it seems to degenerate. The genital organs are situated at the ends
of five interradial branches of the rachis (Fig. 231, gon). Each is an
immense tree-like structure consisting of branching tubes, which are
lined by the sexual cells. So enormous do they become in the
breeding season that they form an article of food among fishermen.
The term esculentus is derived from this circumstance. Other
species are regularly sold for food as Frutta di Mare (Fruit of the
Sea) at Naples, and as "sea eggs" in the West Indian Islands. One
female Echinus esculentus will produce 20,000,000 eggs in a
season.
The so-called blood system is more distinctly developed in
Echinoidea than in Asteroidea and Ophiuroidea. There is an oral ring
of lymphoid tissue surrounding the oesophagus below the water-
vascular ring. From this are given off two strands, the so-called
"dorsal" (Fig. 231, b.v), and "ventral" vessels (Fig. 234, 16), which
run along the two opposite sides of the stomach or first coil of the
alimentary canal. The position of these strands suggests that like the
lacteals of the human intestine they are channels along which the
products of digestion exude from the stomach. The dorsal strand is
situated on the same side as the genital stolon, and from it branches
are given off which ramify on the surface of the stolon, on account of
which this organ, as in Asteroidea, was at one time regarded as a
"heart," but the distinction of the stolon from the strands is easily
made out. An aboral ring enclosing the genital rachis lies embedded
in the septum dividing the aboral sinus (Fig. 234, 20) from the
general coelom.
Classification of Echinoidea.
The Echinoidea are sharply divided into three main orders, which
differ from each other profoundly in their habits and structure. These
are: (1) The Endocyclica or Regular Urchins, of which the species
just described may be taken as the type. (2) The Clypeastroidea or
Cake-urchins, which are of extremely flattened form, and in which
the periproct is shifted from the apical pole so that it is no longer
surrounded by the genital plates, while some of the tube-feet of the
dorsal surface are flattened so as to serve as gills. (3) The
Spatangoidea or Heart-urchins, in which the outline is oval: the
periproct is shifted, as in the Cake-urchins, and the dorsal tube-feet
are similarly modified; but the Heart-urchins have totally lost
Aristotle's lantern, whilst the Cake-urchins have retained it. This
strongly-marked cleavage of the group was primarily due, as in all
such cases, to the adoption of different habits by different members
of the same group. Were we to term the three orders Rock-urchins,
Sand-urchins, and Burrowing-urchins, it would not be entirely true,
for secondary invasions of the other's territory on the part of each
order have undoubtedly taken place; but still the statement would
remain roughly true, and would give a fair idea of the differences in
habitat which have led to the differentiation of the group.